Ameloblastoma

Subtypes

Immunohistochemistry

 

Unicystic ameloblastoma

solid and multicystic ameloblastoma

odontogenic keratocysts

residual cysts

dentigerous cysts

Calretinin

82% (22/27)1, 3/33

94% (29/31)1, 16/163

0/222, 0/173

0/262

0/202

Differential diagnosis

Management

SMA and UA with intramural nodules require  radical treatment. UA without intramural nodules may be treated by enucleation.

References

Philipsen HP, Reichart PA.  Unicystic ameloblastoma.   A review of 193 cases from the literature.  Oral Oncol 1998;34:317-25.

Reichart PA, Philipson HP, Sonner S.  Ameloblastoma; biological profile of 3677 cases.  Oral oncol Eur J Cancer 1995;31B:86-99.

Adv Anat Pathol 1999;6:63. *********

1 Altini, M., Coleman, H., Doglioni, C., Favia, G., Maiorano, E. Calretinin expression in ameloblastomas. Histopathology 2000;37:27-32.

2 Coleman H, Altini M, Ali H, Doglioni C, Favia G, Maiorano E. Use of calretinin in the differential diagnosis of unicystic ameloblastomas. Histopathology 2001;38:312-317.

3 DeVilliers P, Liu H, Suggs C, et al. Calretinin expression in the differential diagnosis of human ameloblastoma and keratocystic odontogenic tumor. Am J Surg Pathol 2008; 32:256-60

This page last revised 5.4.2008.

©SMUHT/PW Bishop